Dendritic cell vaccination and regulatory T-cell depletion augment antitumor immunity after cytotoxic therapy

被引：0
|
作者：
Tanaka, Tomohiro [1 ]
Watanabe, Satoshi [2 ]
Sato, Ko [1 ]
Saida, Yu [1 ]
Baba, Junko [1 ]
Nozaki, Koichiro [1 ]
Ishikawa, Daisuke [1 ]
Igarashi, Natsue [1 ]
Shoji, Satoshi [1 ]
Okajima, Masaaki [1 ]
Miura, Satoru [1 ]
Tanaka, Junta [1 ]
Tanaka, Hiroshi [3 ]
Kagamu, Hiroshi [1 ]
Yoshizawa, Hirohisa [2 ]
Narita, Ichiei [1 ]
机构：
[1] Niigata Univ, Niigata, Japan
[2] Niigata Univ Med & Dent Hosp, Niigata, Japan
[3] Niigata Canc Ctr Hosp, Niigata, Japan
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-2818
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2818
引用
收藏
页数：2
相关论文
共 50 条
  • [31] T-Cell Cancer after CAR T-Cell Therapy
    Mitchell, Emily
    Vassiliou, George S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (22): : 2120 - 2121
  • [32] Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination
    Vedran Radojcic
    Karl B. Bezak
    Mario Skarica
    Maria A. Pletneva
    Kiyoshi Yoshimura
    Richard D. Schulick
    Leo Luznik
    Cancer Immunology, Immunotherapy, 2010, 59 : 137 - 148
  • [33] Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell–based cancer vaccination
    Joanna Galea-Lauri
    James W. Wells
    David Darling
    Phillip Harrison
    Farzin Farzaneh
    Cancer Immunology, Immunotherapy, 2004, 53 : 963 - 977
  • [34] Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination
    Radojcic, Vedran
    Bezak, Karl B.
    Skarica, Mario
    Pletneva, Maria A.
    Yoshimura, Kiyoshi
    Schulick, Richard D.
    Luznik, Leo
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (01) : 137 - 148
  • [35] Regulatory T-cell immunity and its relevance to atherosclerosis
    Taleb, S.
    Tedgui, A.
    Mallat, Z.
    JOURNAL OF INTERNAL MEDICINE, 2008, 263 (05) : 489 - 499
  • [36] Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model
    Lau, Sai Ping
    van Montfoort, Nadine
    Kinderman, Priscilla
    Lukkes, Melanie
    Klaase, Larissa
    van Nimwegen, Menno
    van Gulijk, Mandy
    Dumas, Jasper
    Mustafa, Dana A. M.
    Lievense, Sanne L. A.
    Groeneveldt, Christianne
    Stadhouders, Ralph
    Li, Yunlei
    Stubbs, Andrew
    Marijt, Koen A.
    Vroman, Heleen
    van der Burg, Sjoerd H.
    Aerts, Joachim
    van Hall, Thorbald
    Dammeijer, Floris
    van Eijck, Casper H. J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [37] EFFECT OF INVIVO T-CELL DEPLETION ON THE EFFECTOR T-CELL FUNCTION OF IMMUNITY TO EIMERIA-FALCIFORMIS
    STIFF, MI
    VASILAKOS, JP
    INFECTION AND IMMUNITY, 1990, 58 (06) : 1496 - 1499
  • [38] Regulatory T-cell depletion synergizes with gp96-mediated cellular responses and antitumor activity
    Xiaoli Yan
    Xiaojun Zhang
    Yanzhong Wang
    Xinghui Li
    Saifeng Wang
    Bao Zhao
    Yang Li
    Ying Ju
    Lizhao Chen
    Wenjun Liu
    Songdong Meng
    Cancer Immunology, Immunotherapy, 2011, 60 : 1763 - 1774
  • [39] Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells
    Lundqvist, Andreas
    Yokoyama, Hisayuki
    Smith, Aleah
    Berg, Maria
    Childs, Richard
    BLOOD, 2009, 113 (24) : 6120 - 6127
  • [40] Regulatory T-cell depletion synergizes with gp96-mediated cellular responses and antitumor activity
    Yan, Xiaoli
    Zhang, Xiaojun
    Wang, Yanzhong
    Li, Xinghui
    Wang, Saifeng
    Zhao, Bao
    Li, Yang
    Ju, Ying
    Chen, Lizhao
    Liu, Wenjun
    Meng, Songdong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (12) : 1763 - 1774
12345